Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001997505-26-000002
Filing Date
2026-01-05
Accepted
2026-01-05 17:00:15
Documents
1
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 form4-01052026_050108.html 4  
1 form4-01052026_050108.xml 4 4237
  Complete submission text file 0001997505-26-000002.txt   5609
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Quaggin Susan E (Reporting) CIK: 0001997505 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 26507446